Skip to main content

Healthcare & Biotech

eHealth, BerniePortal Partner to Expand CHOICE Health Plan Access

Image
eHealth, BerniePortal Partner to Expand CHOICE Health Plan Access

Indianapolis – September 23, 2026 -- eHealth, Inc. (Nasdaq: EHTH) has partnered with benefits administration platform BerniePortal to connect more than 5,000 employers and over 1,000 insurance brokers to individual health coverage options under the newly renamed Custom Health Option and Individual Care Expense Arrangements, or CHOICE.

CMS renamed ICHRA to CHOICE arrangements as of September 3, 2026

The Centers for Medicare and Medicaid Services officially rebranded Individual Coverage Health Reimbursement Arrangements as CHOICE arrangements earlier this month, a shift now embedded in the eHealth-BerniePortal distribution model. Under CHOICE, employers provide employees a defined contribution toward individual health coverage rather than a traditional group plan, shifting cost predictability and plan selection to the employee level.

Eskenazi Joins Faculty of 14th Annual IAFA Aesthetic Symposium

Image
Eskenazi Joins Faculty of 14th Annual IAFA Aesthetic Symposium

Miami Beach, Fla. – September 23, 2026 -- Benjamin Eskenazi MD, FACS, founder of Avabello Aesthetics, has been named to the faculty of the 14th Annual IAFA Aesthetic Symposium, set for the Fontainebleau Miami Beach on November 6-7, 2026.

Dr. Eskenazi will co-instruct a pre-symposium injection masterclass on November 5

The five-hour Anatomy & Injection Masterclass runs from 2:00 to 7:00 p.m. and is led by Professor Sebastian Cotofana, MD, PhD, PhD. The course combines cadaver dissections with live patient injection demonstrations and real-time facial ultrasound, covering neurotoxin treatment of the forehead, glabella and crow's feet, and filler treatment of the temples, tear troughs, cheeks, nasolabial folds, lips, chin and jawline. Dr. Eskenazi will perform live injections alongside co-instructors Terry Alford, DMD; Lanna Cheuck, DO; Barbara Brandt, APRN; Jill Campbell, MSN, FNP-C, CANS; and Shanna Concepcion, RN, CANS.

Mölnlycke Report Finds Hospitals Underuse Day Surgery Capacity

Gothenburg – September 23, 2026 -- Mölnlycke Health Care has released The Hidden Capacity Report, an international study identifying significant untapped capacity in day surgery that could improve surgical throughput and reduce waiting times across healthcare systems.

Survey of 256 healthcare professionals across ten countries exposes adoption gaps

The report draws on a review of international literature, a survey of 256 healthcare professionals across ten countries, expert interviews and guidance from an international expert panel of key opinion leaders. Despite strong clinical evidence supporting day surgery, adoption remains inconsistent across countries, healthcare organisations, specialties and individual clinical teams.

GROWNSY Debuts at NANN Conference, Partners on Nasal Congestion Podcast

Image
GROWNSY Debuts at NANN Conference, Partners on Nasal Congestion Podcast

West Palm Beach – September 23, 2026 -- GROWNSY, a baby care brand serving over 3 million households globally, exhibited for the first time at NANN's 42nd Annual Conference held September 15-18, 2026, in West Palm Beach, Florida, marking its entry into the neonatal clinical channel.

GROWNSY showcases NICU-to-home product line at neonatal nursing conference

The company displayed its SniffEase nasal care line alongside a Compact Bottle Sterilizer and Dryer, Electronic Infant Scale with Height Measurement, Postpartum Recovery Kit, and Perineal Massage and Pelvic Floor Wand, targeting families transitioning from NICU care to home routines.

GROWNSY CEO cites nurse engagement as strategic priority

Yvonne, CEO of GROWNSY, said meeting neonatal nurses who guide families from NICU to home reinforced the company's product development rationale.

OxiWear Signs Exclusive Qatar Distribution Deal with AMNM

Image
OxiWear Signs Exclusive Qatar Distribution Deal with AMNM

Doha – September 22, 2026 -- OxiWear Inc. has signed an exclusive distribution partnership with Alfardan Medical with Northwestern Medicine (AMNM) to bring its wearable physiological measurement technology into Qatar, marking the U.S. company's latest push into the Middle East.

OxiWear taps AMNM's local network to enter Qatar's healthcare technology market

Under the agreement, OxiWear and AMNM will jointly handle distribution, market development, and customer engagement for OxiWear's continuous physiological measurement products across Qatar. AMNM, a multi-specialty day-care surgery center based in Lusail and operated in affiliation with Chicago-based Northwestern Medicine, provides OxiWear with an established clinical network and regional expertise in outpatient care.

Apollo-Backed Forge to Acquire Becker's Healthcare from Pamlico Capital

Image
Apollo-Backed Forge to Acquire Becker's Healthcare from Pamlico Capital

New York – September 22, 2026 -- Forge, the B2B events and media company backed by Apollo, has agreed to acquire Becker's Healthcare from Pamlico Capital, adding a platform that reaches more than 1.5 million healthcare leaders and executives.

Becker's Healthcare brings a 15,000-attendee live events network to the deal

Chicago-based Becker's Healthcare hosts more than 15,000 attendees annually across its live events, serving hospital, health system and healthcare executives through digital products, executive communities and conferences.

Anonymous Donor Gives $100M to Princess Margaret Cancer Foundation

Image
Anonymous Donor Gives $100M to Princess Margaret Cancer Foundation

Toronto – September 22, 2026 -- The Princess Margaret Cancer Foundation has secured a $100 million gift from an anonymous donor, the largest single donation in the foundation's history and the largest cancer-related gift ever recorded in Canada.

Foundation launches $2.5 billion campaign to fund cancer breakthroughs

The gift anchors the launch of "Carry The Fire," a $2.5 billion fundraising campaign aimed at accelerating cancer research, treatment and care at Princess Margaret Cancer Centre. The donation, tied to the donor's personal experience with cancer, will be directed toward the Centre's highest-priority needs across research, education and patient care, giving administrators flexibility to fund breakthroughs as they emerge.

Aflac Delivers Robotic Ducks to Pediatric Cancer Patients in St. Louis

Image
Aflac Delivers Robotic Ducks to Pediatric Cancer Patients in St. Louis

St. Louis – September 22, 2026 -- Aflac Incorporated brought its My Special Aflac Duck robotic companion to pediatric cancer and sickle cell disease patients at SSM Health Cardinal Glennon Children's Hospital, part of a program that has distributed nearly 50,000 units free of charge since 2018 across the U.S., Japan and Northern Ireland.

Former MLB and NFL player Brian Jordan joined Aflac U.S. President Virgil Miller to read his children's book at the event

Jordan, who played seven Major League Baseball seasons in St. Louis before founding the Brian Jordan Foundation, read his book "I Told You I Can Play" to patients and families, distributing copies alongside the duck deliveries.

Danaher Sets Q3 2026 Earnings Call for October 21

Washington – September 22, 2026 -- Danaher Corporation (NYSE: DHR) will hold its third-quarter 2026 earnings conference call on Wednesday, October 21, 2026, at 8:00 a.m. ET, the company confirmed.

Danaher to webcast hour-long Q3 results discussion on October 21

The call, lasting approximately one hour, will be webcast via the "Investors" section of Danaher's website under "Events & Presentations," alongside a slide presentation. Investors can dial in at 800-267-6316 within the U.S. or +1 203-518-9783 outside the U.S., using Conference ID DHRQ326.

Genomma Lab Declares $200 Million Peso Dividend, Its 17th Payout

Mexico City – September 22, 2026 -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) has filed a Notice of Rights with the Bolsa Mexicana de Valores declaring a cash dividend of $0.20 Mexican pesos per common share, totaling $200,000,000.00 pesos based on shares currently outstanding.

Board authorizes 17th dividend under shareholder mandate

The payment marks the company's seventeenth dividend distribution and was approved by Genomma Lab's Board of Directors under powers delegated at the Annual General Shareholders Meeting held on April 24, 2025. The per-share amount is calculated against the total number of LABB shares outstanding on the Mexican Stock Exchange.